|
gptkbp:instanceOf
|
analgesic
alkaloid
opioid
|
|
gptkbp:antidote
|
gptkb:naloxone
|
|
gptkbp:aroma
|
odorless
|
|
gptkbp:ATCCode
|
N02AA01
|
|
gptkbp:CASNumber
|
57-27-2
|
|
gptkbp:chemicalFormula
|
C17H19NO3
|
|
gptkbp:color
|
white (as pure powder)
|
|
gptkbp:derivedFrom
|
gptkb:opium_poppy
|
|
gptkbp:discoveredBy
|
gptkb:Friedrich_Sertürner
|
|
gptkbp:discoveredIn
|
1804
|
|
gptkbp:eliminationHalfLife
|
2–4 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:flavor
|
bitter
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
morphine
|
|
gptkbp:IUPACName
|
(5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
|
|
gptkbp:KEGGID
|
D08210
|
|
gptkbp:legalStatus
|
controlled substance
|
|
gptkbp:marketedAs
|
1827
|
|
gptkbp:meltingPoint
|
254°C
|
|
gptkbp:MeSH_ID
|
D009020
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
285.34 g/mol
|
|
gptkbp:pregnancyCategory
|
C
|
|
gptkbp:producedBy
|
gptkb:Papaver_somniferum
|
|
gptkbp:PubChem_CID
|
4447447
5288826
CHEMBL44957
DB00295
|
|
gptkbp:riskFactor
|
addiction
overdose
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
subcutaneous
intravenous
rectal
epidural
intrathecal
|
|
gptkbp:scheduleUS
|
gptkb:Schedule_II
|
|
gptkbp:sideEffect
|
nausea
vomiting
constipation
drowsiness
respiratory depression
|
|
gptkbp:solubility
|
60 mg/L (20°C)
|
|
gptkbp:synonym
|
gptkb:MS_Contin
gptkb:Avinza
gptkb:Kadian
gptkb:Oramorph
morphia
|
|
gptkbp:target
|
gptkb:delta-opioid_receptor
gptkb:kappa-opioid_receptor
gptkb:mu-opioid_receptor
|
|
gptkbp:UNII
|
76I7G6D29C
|
|
gptkbp:usedFor
|
pain management
|
|
gptkbp:bfsParent
|
gptkb:Codeine
gptkb:Thebaine
gptkb:Heroin
gptkb:Papaver
gptkb:Papaver_somniferum
gptkb:codeine
gptkb:M6G
gptkb:Neonatal_abstinence_syndrome
gptkb:Opium_poppy
gptkb:Papaveraceae
gptkb:Project_ARTICHOKE
gptkb:Project_Artichoke
gptkb:opioid
gptkb:Friedrich_Sertürner
gptkb:alkaloid
|
|
gptkbp:bfsLayer
|
6
|